Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by JOHNSON, J. D.
Right arrow Articles by OBER, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JOHNSON, J. D.
Right arrow Articles by OBER, R. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1984 Oxford University Press

research-article

Cholestyramine-Enhanced Fecal Elimination of Carbon-14 in Rats after Administration of Ammonium [14C]Perfluorooctanoate or Potassium [14C]Perfluorooctanesulfonate

JAMES D. JOHNSON1, SHEILA J. GIBSON and ROBERT E. OBER

Riker Laboratories, Inc. 3M Center, Building 270-3S-05, St. Paul, Minnesota 55144

Cholestyramine-Enhanced Fecal Elimination of Carbon-14 in Rats after Administration of Ammonium [14C]Perfluorooctanoate or Potassium [l4C]Perfluorooctanesulfonate. JOHNSON, J. D., GIBSON, S. J., AND OBER, R. E. (1984). Fundam. Appl. Toxicol. 4, 972–976. After a single intravenous dose of ammonium [l4C]perfluorooctanoate ([14C]PFO, 13.3 mg/kg) or of potassium [14C]perfluorocctanesulfonate ([14C]PFOS, 3.4 mg/kg) to rats, cholestyramine fed daily as a 4% mixture in feed was shown to increase the total carbon-14 eliminated via feces and to decrease liver concentration of carbon-14. Rats were fed cholestyramine in feed for 14 days after administration of [14C]PFO and for 21 days after administration of [14C]PFOS. Control rats were administered radiolabeled fluorochemical but were not treated with cholestyramine. Cholestyramine treatment increased mean cumulative carbon-14 elimination in feces by 9.8-fold for rats administered [14C]PFO and by 9.5-fold for rats administered [14C]PFOS. After [14C]PFO, a mean of 4% of the dose of carbon-14 was in liver of cholcstyramine-trcated rats at 14 days versus 7.6% in control rats; after [14C]PFOS, 11.3% of the dose was in liver at 21 days versus 40.3% in control rats. After administration of either radiolabeled compound, plasma and red blood cell carbon-14 concentrations, which were relatively lower than liver concentrations, were also significantly reduced by cholestyramine treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.